Back
Belite Bio 10K Form
Buy
89
BLTE
Belite Bio
Last Price:
64.58
Seasonality Move:
11.16%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
10K form not available
Receive BLTE News And Ratings
See the #1 stock for the next 7 days that we like better than BLTE
BLTE Financial Statistics
Sales & Book Value
| Annual Sales: | -- |
|---|---|
| Cash Flow: | $0 |
| Price / Cash Flow: | 0 |
| Annual Sales: | $3.63 |
| Price / Book: | 17.62 |
Profitability
| EPS (TTM): | -1.10000 |
|---|---|
| Net Income (TTM): | $-33.03M |
| Gross Margin: | -- |
| Return on Equity: | 0% |
| Return on Assets: | 0% |
Belite Bio Earnings Forecast
Key Belite Bio Financial Ratios
- The Interest Expense is -0.08% of Operating Income.
- Per Share Earnings over the last 4 years have been positive in 0 years.
Belite Bio Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NASDAQ |
|---|---|
| Industry: | Pharmaceuticals |
| Sector: | Health Care |
| Current Symbol: | BLTE |
| Website: | belitebio.com |
Debt
| Debt-to-Equity Ratio: | 0 |
|---|---|
| Current Ratio: | 0 |
| Quick Ratio: | 0 |
Price-to-Earnings
| Trailing P/E Ratio: | 0 |
|---|---|
| Forward P/E Ratio: | 0 |
BLTE Technical Analysis vs Fundamental Analysis
Buy
89
Belite Bio (BLTE)
is a Buy
Is Belite Bio a Buy or a Sell?
-
Belite Bio stock is rated a Buy
The current Belite Bio [BLTE] share price is $64.02. The Score for BLTE is 89, which is 78% above its historic median score of 50, and infers lower risk than normal.